Alkermes plc. (ALKS) Form 8-K Material Events
Alkermes plc. (ALKS) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ALKS
CIK: 1520262
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerJohn Charters Jr
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-09 | 2026-10-08 | PRIMARY DOCUMENT | 0001520262-26-000131 | View SEC Doc Filr Page |
| 4 | 2026-10-09 | 2026-10-07 | PRIMARY DOCUMENT | 0001520262-26-000130 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-10-02 | PRIMARY DOCUMENT | 0001520262-26-000127 | View SEC Doc Filr Page |
| 144 | 2026-10-02 | — | 144 Filing | 0001964306-26-000464 | View SEC Doc Filr Page |
| 8-K | 2026-09-21 | 2026-09-21 | 8-K | 0001193125-26-396065 | View SEC Doc Filr Page |
| 3 | 2026-09-18 | 2026-09-14 | PRIMARY DOCUMENT | 0001520262-26-000125 | View SEC Doc Filr Page |
| 8-K | 2026-09-16 | 2026-09-14 | FORM 8-K | 0001193125-26-392527 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-03 | PRIMARY DOCUMENT | 0001520262-26-000120 | View SEC Doc Filr Page |
| 144 | 2026-09-03 | — | 144 Filing | 0001964306-26-000424 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-09-01 | PRIMARY DOCUMENT | 0001520262-26-000118 | View SEC Doc Filr Page |
| 144 | 2026-09-01 | — | 144 Filing | 0001964306-26-000417 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-17 | PRIMARY DOCUMENT | 0001520262-26-000116 | View SEC Doc Filr Page |
| 144 | 2026-08-17 | — | 144 Filing | 0001964306-26-000396 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-12 | 8-K | 0001193125-26-345901 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-05 | PRIMARY DOCUMENT | 0001520262-26-000113 | View SEC Doc Filr Page |
| 4 | 2026-08-03 | 2026-08-03 | PRIMARY DOCUMENT | 0001520262-26-000111 | View SEC Doc Filr Page |
| 4 | 2026-08-03 | 2026-08-03 | PRIMARY DOCUMENT | 0001520262-26-000110 | View SEC Doc Filr Page |
| 4 | 2026-08-03 | 2026-08-03 | PRIMARY DOCUMENT | 0001520262-26-000109 | View SEC Doc Filr Page |
| 144 | 2026-08-03 | — | 144 Filing | 0001964306-26-000352 | View SEC Doc Filr Page |
| 144 | 2026-08-03 | — | 144 Filing | 0001964306-26-000351 | View SEC Doc Filr Page |
| 144 | 2026-08-03 | — | 144 Filing | 0001964306-26-000350 | View SEC Doc Filr Page |
| 8-K/A | 2026-08-03 | 2026-02-24 | 8-K/A | 0001193125-26-330564 | View SEC Doc Filr Page |
| S-8 | 2026-07-28 | — | S-8 | 0001193125-26-321193 | View SEC Doc Filr Page |
| 10-Q | 2026-07-28 | 2026-06-30 | 10-Q | 0001193125-26-319022 | View SEC Doc Filr Page |
| 8-K | 2026-07-28 | 2026-07-28 | 8-K | 0001193125-26-318844 | View SEC Doc Filr Page |